AMP
61
-3
ADBE
57
2
BAC
62
5
HBAN
90
8
PVH
49
6
JWN
65
4
GD
55
-2
TDC
75
8
UPS
48
10
CTSH
63
4
APA
55
5
STI
15
-11
ZBH
57
6
WYNN
50
6
CRM
59
7
AAPL
48
9
T
66
-5
STT
79
6
TEL
71
8
KMB
37
-7
AMP
61
-3
ADBE
57
2
BAC
62
5
HBAN
90
8
PVH
49
6
JWN
65
4
GD
55
-2
TDC
75
8
UPS
48
10
CTSH
63
4
APA
55
5
STI
15
-11
ZBH
57
6
WYNN
50
6
CRM
59
7
AAPL
48
9
T
66
-5
STT
79
6
TEL
71
8
KMB
37
-7
Financhill
Back

Lineage Cell Therapeutics Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
44

LCTX
Lineage Cell Therapeutics

Last Price:
$0.47
Seasonality Move:
-3.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Lineage Cell Therapeutics Stock Forecast

  • Is Lineage Cell Therapeutics Stock Undervalued?
    The current Lineage Cell Therapeutics [LCTX] share price is $0.48. The Score for LCTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • LCTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Lineage Cell Therapeutics Stock Go Up Next Year?

Data Unavailable

Lineage Cell Therapeutics Stock Rating

Data Unavailable

Lineage Cell Therapeutics Stock Price History

Is LCTX stock going to rise?

  • The current trend is relatively stagnant and LCTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lineagecell.com

52-Week Data

52-Week High:
1.17
52-Week Low:
0.37

Prediction Charts

Market Cap:
109.4M
Price in USD:
0.48
Volume:
874.2K
Beta:
1.26

Technical Analysis

SMA50:
0.47
SMA100:
0.54
SMA200:
0.69
52-Wk Change:
-59.05%

Stock Predictions

  • Is Lineage Cell Therapeutics stock public?
    Yes, Lineage Cell Therapeutics is a publicly traded company.
  • What is the Lineage Cell Therapeutics stock quote today?
    The Lineage Cell Therapeutics stock price is 0.48 USD today.
  • How to buy Lineage Cell Therapeutics stock online?
    You can buy Lineage Cell Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-24 0.47 0.50 0.50 0.46
Apr-25 0.50 0.49 0.51 0.46
Apr-28 0.50 0.46 0.51 0.46
Apr-29 0.46 0.47 0.48 0.46
Apr-30 0.47 0.50 0.50 0.47
May-1 0.50 0.50 0.51 0.47
May-2 0.49 0.49 0.50 0.47
May-5 0.49 0.46 0.49 0.46
May-6 0.47 0.44 0.48 0.43
May-7 0.43 0.44 0.44 0.43
May-8 0.43 0.47 0.48 0.43
May-9 0.47 0.44 0.47 0.44
May-12 0.46 0.48 0.49 0.45
May-13 0.47 0.47 0.48 0.45

Lineage Cell Therapeutics Earnings

Data Unavailable

Lineage Cell Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.

* Lineage Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.